Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund period 3 cell therapy trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, declaring (PDF) for an I...

Frazier Life Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an even further $630 million for its fund concentrat...

GigaGen gets approximately $135M BARDA money to hammer botulism

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its own ...

GPCR agency Septerna files for IPO on strength of preclinical data

.Septerna is about to determine just how a biotech without "any type of meaningful clinical informat...

Kurma finalizes to begin with $154M haul for largest biotech fund as yet

.International VC firm Kurma Partners has actually introduced its own newest biotech fund, along wit...

Prothena advertises one director while yet another leaves behind-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings as w...

Editas capitalize Tip Cas9 licensing civil liberties for $57M

.Against the background of a Cas9 patent fight that declines to die, Editas Medicine is cashing in a...

Ultragenyx tweaks gene treatment dosing to call up efficiency

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson ailment gene treatment UX701 ha...

Biopharma unemployment cost supports in Q3: Brutal Biotech analysis

.As summertime warmth relies on cool winds, really hopes that this year would certainly bring extens...

J &amp J loses period 2 dengue applicant in newest switch from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious disease pipe has claimed an additiona...